Irrigation fluid absorption through opened prostatic venous sinuses during transurethral resection
Transurethral resection of the prostate (TURP) is performed inside a closed hydraulic system: a continuous flow of irrigating fluid distends the bladder and prostatic fossa while the resectoscope loop shaves away obstructing adenoma tissue. Every pass of the loop that transects a venous sinus in the prostatic capsule creates a direct, low-resistance conduit between the irrigant reservoir and the systemic venous circulation.
During TURP, irrigant flows continuously through a sheath into the bladder and prostatic fossa and drains back out. The prostate itself is richly vascularized, with a plexus of low-pressure venous sinuses embedded within its capsule. As the surgeon resects the adenoma with the electrocautery loop, each pass that reaches the surgical capsule exposes and often transects several of these venous channels.
Because the resection cavity is continuously bathed in pressurized irrigant, any open venous sinus becomes a direct portal between the irrigation reservoir and the patient's venous return. Unlike a peripheral IV line, there is no valve, no regulated rate, and no alarm — absorption is silent and proceeds for as long as the sinus remains open and a favorable pressure gradient exists.
Absorption is not an occasional complication of TURP — it is the expected physiological consequence of resecting through a vascular organ under a column of pressurized fluid. The clinical question is never "whether" absorption occurs, but "how much."
Fluid absorption follows simple hydraulic principles: flow is proportional to the pressure gradient between the irrigant column and the venous lumen, divided by the resistance of the opened sinus. The irrigant bag is typically suspended 60 cm above the pubic symphysis, generating enough hydrostatic pressure to keep the field distended and visible — but this same pressure is what forces fluid into any breached vein.
Raising the bag increases visualization but also increases absorption; lowering it reduces absorption but can compromise the surgical view via a collapsed field and bleeding obscuring vision. Classic teaching sets a ceiling around 60 cm (roughly 40–70 cm depending on the resectoscope and technique) as a compromise between visibility and safety.
Intravesical/venous pressure also matters: a distended bladder or high venous back-pressure opposes inflow, while a low-pressure venous bed (e.g., in hypovolemic or hypotensive patients) favors it.
Conventional monopolar resectoscopes pass electrical current through the tissue between the active loop electrode and a distant grounding pad. Normal saline is electrically conductive and would disperse the cutting current throughout the irrigant, preventing effective cautery and risking dispersed burns. Monopolar TURP therefore requires an electrically inert, non-conductive irrigant — historically 1.5% glycine, and less commonly sorbitol-mannitol or plain sorbitol/mannitol mixtures.
The unavoidable trade-off: every non-conductive irrigant used with monopolar technology is, by chemical necessity, hypotonic or non-physiologic relative to plasma, so any significant absorbed volume disturbs serum tonicity — setting up the entire pathophysiologic cascade of TUR syndrome.
Once glycine solution enters the venous circulation in appreciable volume, its low osmolality begins diluting the extracellular sodium concentration. Because glycine crosses cell membranes and is metabolized relatively slowly, the resulting hyponatremia is compounded by an osmotic component — free water effectively shifts into cells, worsening both the biochemical and clinical picture.
Serum sodium concentration is, to a first approximation, total body sodium divided by total body water. Rapidly infusing several liters of a fluid containing essentially no sodium expands the water compartment without adding solute, diluting the existing sodium pool. Because absorption during TURP can occur over just tens of minutes — far faster than the kidneys can excrete free water — this is an acute dilutional hyponatremia, the most dangerous kind, since the brain has no time to adapt by extruding intracellular osmoles.
As a working clinical estimate, each liter of hypotonic glycine absorbed lowers serum sodium by roughly 5–8 mmol/L, though the exact fall depends on the patient's baseline total body water, cardiac and renal status, and the composition of the specific irrigant used.
Glycine is not physiologically silent. It is the simplest amino acid and a major inhibitory neurotransmitter in the spinal cord, brainstem, and retina, acting through glycine-gated chloride channels. When absorbed in large quantity it is metabolized primarily in the liver to glyoxylic acid and ammonia — transient hyperammonemia can itself cause encephalopathy independent of the sodium level, occasionally mimicking or amplifying the neurologic picture of hyponatremia.
This dual mechanism — osmotic dilution of sodium plus a pharmacologically active solute with CNS and retinal receptor activity — is why TUR syndrome with glycine tends to produce a broader symptom complex (including visual disturbance) than dilutional hyponatremia from an inert fluid alone.
A serum sodium below 125 mmol/L is the classic threshold used in urology literature to anticipate the onset of clinically apparent TUR syndrome; below 120 mmol/L, cerebral edema and seizure risk rise sharply, and below ~100–110 mmol/L cardiovascular collapse becomes a real threat.
Because standard general or spinal anesthesia can mask early neurologic warning signs, TUR syndrome is often first suspected in an awake (spinal-anesthetized) patient who reports headache, nausea, or visual blurring, or in any patient who develops unexplained bradycardia, hypertension, or a widened pulse pressure mid-procedure.
Modern practice increasingly uses intraoperative point-of-care sodium measurement, ethanol-tagged irrigant absorption monitoring, or simply strict tracking of the deficit between irrigant instilled and irrigant recovered as a surrogate for absorbed volume — allowing the surgical team to halt resection before sodium falls to dangerous levels.
The clinical syndrome of TUR syndrome reflects two converging insults: cerebral edema from acute hypotonic dilution, and direct pharmacologic/toxic effects of absorbed glycine and its metabolites. Cardiovascular findings evolve in a characteristic biphasic pattern as intravascular volume expansion gives way to myocardial and vascular decompensation.
Acute hypotonic hyponatremia drives water into brain cells faster than they can adapt, producing cerebral edema within an essentially fixed cranial vault. The clinical spectrum tracks the degree and speed of the sodium fall:
• Mild (Na 125–135 mmol/L): restlessness, headache, nausea, mild confusion — often the first clues in an awake patient • Moderate (Na 115–125 mmol/L): marked confusion, agitation or lethargy, visual disturbances ranging from blurred vision to transient blindness (glycine acting at retinal glycine receptors, sometimes compounded by ammonia) • Severe (Na <115–110 mmol/L): seizures, obtundation, coma, brainstem herniation risk in extreme cases
The visual symptoms are a relatively distinctive clue pointing toward glycine-specific toxicity rather than hyponatremia from an inert irrigant, and typically resolve within about 24 hours as glycine is metabolized and cleared.
Cardiovascular findings evolve as absorbed volume accumulates:
Early phase — volume expansion: acute intravascular volume loading triggers a baroreceptor-mediated reflex bradycardia together with a rise in systemic blood pressure (and often a widened pulse pressure) as the heart responds to increased preload. This combination — unexplained bradycardia with hypertension mid-resection — is a classic early warning sign.
Late phase — decompensation: as hyponatremia deepens and myocardial conduction is disturbed by both the electrolyte disturbance and direct glycine/ammonia toxicity, the picture can shift abruptly to hypotension, arrhythmia (including bradyarrhythmias progressing to asystole in extreme cases), pulmonary edema from volume overload, and cardiovascular collapse.
Because spinal or epidural anesthesia is common for TURP and keeps the patient awake, subjective symptoms — headache, nausea, visual change, restlessness — are often the earliest and most sensitive indicator of evolving TUR syndrome, frequently preceding measurable vital sign changes.
TUR syndrome can mimic or coexist with several other perioperative problems, complicating diagnosis: bladder perforation with extravasation (which itself causes fluid overload without necessarily severe hyponatremia), sepsis from bacteriuria, myocardial infarction, or a high spinal block. A high index of suspicion — combined with rapid point-of-care serum sodium measurement — remains the key diagnostic step whenever a TURP patient develops unexplained confusion, visual change, or hemodynamic instability during or shortly after resection.
The probability and severity of TUR syndrome are not random — they scale predictably with a small number of measurable procedural and anatomic variables. Recognizing high-risk combinations before and during surgery allows the operative team to adjust technique, set firm time limits, and escalate monitoring proactively rather than reactively.
Because absorption accrues at roughly 10–30 mL for every minute of active resection, total absorbed volume — and therefore sodium fall — is directly proportional to how long the surgeon spends resecting. Landmark series (notably Mebust and colleagues' multi-institutional review of thousands of TURPs) identified resection times beyond approximately 60–90 minutes as carrying a sharply elevated risk of clinically significant TUR syndrome and associated mortality.
This single variable underlies the long-standing surgical dictum to complete a TURP, whenever feasible, in under 60 minutes — a rule of thumb that predates modern point-of-care monitoring and remains clinically relevant today.
Several additional factors compound or independently elevate risk:
• Gland size: larger adenomas (typically cited above ~45 g) require more tissue to be resected, more venous sinuses to be opened, and proportionally longer operative time • Number and caliber of opened sinuses: more aggressive or deeper resection, particularly near the capsule, exposes larger venous channels with lower resistance to flow • Irrigation bag height / hydrostatic pressure: a higher bag increases the driving pressure for absorption; classic teaching caps height around 60 cm • Low venous or intravesical pressure: hypovolemic or hypotensive patients present a more favorable pressure gradient for fluid to enter the venous system • Surgeon experience: less experienced operators tend to have longer resection times and may enter the capsule or open larger sinuses more often
The same absorbed volume produces more severe consequences in some patients than others. Elderly patients, those with pre-existing cardiac disease or reduced cardiac reserve, small body habitus (smaller total body water, so the same absorbed volume causes a larger dilutional effect), and patients on diuretics with a lower baseline sodium are all disproportionately vulnerable to both the fluid-overload and hyponatremic components of the syndrome. These patient factors are why absolute absorbed volume thresholds are used cautiously — clinical response and rate of change matter as much as the raw number.
The single most effective intervention against TUR syndrome is technological: bipolar resection systems confine the cutting current between two electrodes mounted on the loop itself, so the circuit no longer needs to pass through the patient's body via a non-conductive irrigant. This allows the use of isotonic normal saline, removing the hypotonic-dilution mechanism entirely, independent of how much fluid is absorbed.
In bipolar resectoscopes, both the active and return electrodes are built into the loop assembly, so current flows locally between the two poles rather than through the patient to a distant grounding pad. Because the irrigant no longer forms part of the electrical circuit, ordinary isotonic 0.9% normal saline can be used throughout the procedure.
Since saline is isotonic with plasma, any absorbed volume dilutes sodium negligibly compared with glycine — for practical purposes, the dilutional hyponatremia mechanism of TUR syndrome is eliminated. Multiple randomized trials and meta-analyses comparing bipolar-saline with monopolar-glycine TURP have found essentially no cases of hyponatremic TUR syndrome in bipolar cohorts, alongside comparable resection efficacy and shorter catheterization times. Large-volume absorption can still theoretically cause dilutional/volume-overload effects with saline, but the severe hyponatremic and glycine-toxic components are avoided.
Bipolar technology does not reduce the volume of fluid absorbed through opened venous sinuses — it changes what is absorbed. By making the irrigant isotonic, it converts a potentially lethal hyponatremic emergency into, at worst, a manageable volume-load issue.
Where bipolar equipment is unavailable, risk is minimized by: limiting resection time to well under 60–90 minutes (staging very large glands across two procedures if needed), keeping irrigation bag height as low as practically allows adequate visualization (commonly ≤60 cm above the symphysis), using continuous-flow resectoscopes that reduce intravesical pressure buildup, monitoring for early clinical warning signs (bradycardia with hypertension, patient-reported headache or visual change under spinal anesthesia), and checking serum sodium intraoperatively if resection is prolonged or symptoms emerge. Alternative non-conductive irrigants such as sorbitol-mannitol mixtures are sometimes used, but they carry the same fundamental hypotonic-dilution risk as glycine.
Once TUR syndrome is suspected or confirmed: resection is stopped and completed as quickly as safely possible; the airway, breathing, and circulation are supported; serum sodium, potassium, and osmolality are checked immediately; and fluid overload is addressed with loop diuretics (e.g., furosemide) once hemodynamically appropriate.
For symptomatic or severe hyponatremia (typically <120 mmol/L with neurologic symptoms), hypertonic saline (3% NaCl) is infused under close monitoring to raise sodium. Correction must be deliberately slow and capped — generally no more than about 8–10 mmol/L over 24 hours — because overly rapid correction of hyponatremia risks osmotic demyelination syndrome (central pontine myelinolysis), a devastating and often irreversible neurologic injury. Seizures are managed with benzodiazepines, and cardiovascular support (vasopressors, antiarrhythmics) is provided as needed while sodium is corrected gradually and the underlying volume overload resolves.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Monopolar + 1.5% Glycine | Current passes through patient to grounding pad | Requires non-conductive, hypotonic irrigant (≈200 mOsm/L) | TUR syndrome incidence ≈1–8%; classic teaching, still widely used |
| Bipolar + 0.9% Saline | Current confined between electrodes on the loop | Permits isotonic irrigant (≈308 mOsm/L) | Hyponatremic TUR syndrome incidence ≈0%; comparable resection efficacy |
| Monopolar + Sorbitol-Mannitol | Current passes through patient to grounding pad | Non-conductive but still hypotonic/non-physiologic | Slightly different metabolic profile; same fundamental dilution risk as glycine |
| Laser enucleation (HoLEP/ThuLEP) | No monopolar/bipolar current through irrigant | Uses saline irrigation with laser energy, not electrocautery | Essentially no TUR syndrome risk; alternative technique for large glands |